New patent for Mylan Ireland drug YUPELRI

March 5, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for YUPELRI Yupelri is a drug marketed by Mylan Ireland Ltd and is included in one NDA. It is available from one supplier. There are fifteen…

The post New patent for Mylan Ireland drug YUPELRI appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.